These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

888 related items for PubMed ID: 29679490

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. The early expansion of anergic NKG2Apos/CD56dim/CD16neg natural killer represents a therapeutic target in haploidentical hematopoietic stem cell transplantation.
    Roberto A, Di Vito C, Zaghi E, Mazza EMC, Capucetti A, Calvi M, Tentorio P, Zanon V, Sarina B, Mariotti J, Bramanti S, Tenedini E, Tagliafico E, Bicciato S, Santoro A, Roederer M, Marcenaro E, Castagna L, Lugli E, Mavilio D.
    Haematologica; 2018 Aug; 103(8):1390-1402. PubMed ID: 29700172
    [Abstract] [Full Text] [Related]

  • 24. Distribution of several activating and inhibitory receptors on CD3(-)CD56(+) NK cells in regional lymph nodes of melanoma patients.
    Vuletić A, Jurišić V, Jovanić I, Milovanović Z, Nikolić S, Konjević G.
    J Surg Res; 2013 Aug; 183(2):860-8. PubMed ID: 23522458
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Natural Killer Lymphocytes Are Dysfunctional in Kidney Transplant Recipients on Diagnosis of Cancer.
    Peraldi MN, Berrou J, Venot M, Chardiny V, Durrbach A, Vieillard V, Debré P, Charron D, Suberbielle C, Chevret S, Glotz D, Dulphy N, Toubert A.
    Transplantation; 2015 Nov; 99(11):2422-30. PubMed ID: 26798861
    [Abstract] [Full Text] [Related]

  • 29. Distinct natural killer cells in HIV-exposed seronegative subjects with effector cytotoxic CD56(dim) and CD56(bright) cells and memory-like CD57⁺NKG2C⁺CD56(dim) cells.
    Lima JF, Oliveira LM, Pereira NZ, Mitsunari GE, Duarte AJ, Sato MN.
    J Acquir Immune Defic Syndr; 2014 Dec 15; 67(5):463-71. PubMed ID: 25230289
    [Abstract] [Full Text] [Related]

  • 30. Assay of T- and NK-cell subsets and the expression of NKG2A and NKG2D in patients with new-onset systemic lupus erythematosus.
    Li WX, Pan HF, Hu JL, Wang CZ, Zhang N, Li J, Li XP, Xu JH, Ye DQ.
    Clin Rheumatol; 2010 Mar 15; 29(3):315-23. PubMed ID: 20012119
    [Abstract] [Full Text] [Related]

  • 31. Co-infection of Cytomegalovirus and Epstein-Barr Virus Diminishes the Frequency of CD56dimNKG2A+KIR- NK Cells and Contributes to Suboptimal Control of EBV in Immunosuppressed Children With Post-transplant Lymphoproliferative Disorder.
    Lam JKP, Azzi T, Hui KF, Wong AMG, McHugh D, Caduff N, Chan KH, Münz C, Chiang AKS.
    Front Immunol; 2020 Mar 15; 11():1231. PubMed ID: 32625211
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Increased expression of the natural killer cell inhibitory receptor CD94/NKG2A and CD158b on circulating and lesional T cells in patients with chronic plaque psoriasis.
    Liao YH, Jee SH, Sheu BC, Huang YL, Tseng MP, Hsu SM, Tsai TF.
    Br J Dermatol; 2006 Aug 15; 155(2):318-24. PubMed ID: 16882169
    [Abstract] [Full Text] [Related]

  • 35. CD16- CD56+ natural killer cells after bone marrow transplantation.
    Jacobs R, Stoll M, Stratmann G, Leo R, Link H, Schmidt RE.
    Blood; 1992 Jun 15; 79(12):3239-44. PubMed ID: 1375847
    [Abstract] [Full Text] [Related]

  • 36. Overexpression of CD158 and NKG2A Inhibitory Receptors and Underexpression of NKG2D and NKp46 Activating Receptors on NK Cells in Acute Myeloid Leukemia.
    Sandoval-Borrego D, Moreno-Lafont MC, Vazquez-Sanchez EA, Gutierrez-Hoya A, López-Santiago R, Montiel-Cervantes LA, Ramírez-Saldaña M, Vela-Ojeda J.
    Arch Med Res; 2016 Jan 15; 47(1):55-64. PubMed ID: 26876298
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Percentages and functions of natural killer cell subsets in peripheral blood of patients with severe aplastic anemia].
    Li ZS, Shao ZH, Fu R, Wang J, Li LJ, Zhang T, Wang HQ, Wu YH, Ruan EB, Song J, Qu W, Liu H, Xing LM, Wang XM, Liang Y, Guan J, Wang GJ.
    Zhonghua Yi Xue Za Zhi; 2011 Apr 26; 91(16):1084-7. PubMed ID: 21609587
    [Abstract] [Full Text] [Related]

  • 39. An unusual CD56(bright) CD16(low) NK cell subset dominates the early posttransplant period following HLA-matched hematopoietic stem cell transplantation.
    Dulphy N, Haas P, Busson M, Belhadj S, Peffault de Latour R, Robin M, Carmagnat M, Loiseau P, Tamouza R, Scieux C, Rabian C, Di Santo JP, Charron D, Janin A, Socié G, Toubert A.
    J Immunol; 2008 Aug 01; 181(3):2227-37. PubMed ID: 18641363
    [Abstract] [Full Text] [Related]

  • 40. Peritoneal natural killer cells from epithelial ovarian cancer patients show an altered phenotype and bind to the tumour marker MUC16 (CA125).
    Belisle JA, Gubbels JA, Raphael CA, Migneault M, Rancourt C, Connor JP, Patankar MS.
    Immunology; 2007 Nov 01; 122(3):418-29. PubMed ID: 17617155
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 45.